Optiscan Imaging Limited
Optiscan Imaging makes and develops microscopes and related technologies for examining tissue at the cellular and sub-cellular level. The company's original technology, Stratum, uses fluorescent imaging in the detection and treatment of skin cancer, which has reached epidemic proportions in the nation where Optiscan Imaging is headquartered -- Australia. Optiscan Imaging later worked on the development of a miniature scanner to be used in endoscopes, which led to a partnership with Pentax. Together they developed a confocal flexible endo-microscope product, launched in 2005. Optiscan has been in business since 1988.
Contact Details
Executives
Chairman
Grant F. Latta
CEO
Vicki Tutungi